Saint-Paul (Nice), Ch. Sattonet (Cagnes s/mer) SNIFF 17 study Angers ,
Fibrostar study Hepatologists ,
Grenoble.s We also thank the following contributors: Gilles Hunault ,
clinical research funding program) of the French Department of Health for SNIFF 17 ANRS (French national agency for AIDS and Viral Hepatitis) for HC EP 23 Fibrostar, 1994. ,
4 Department of Cell and Tissue Pathology References 1. Intraobserver and interobserver variations in liver biopsy interpretation in patients with chronic hepatitis C. The French METAVIR Cooperative Study Group, Liver-Gastroenterology department Hepatology, vol.20, issue.51, pp.15-20, 1994. ,
Histological grading and staging of chronic hepatitis, Journal of Hepatology, vol.22, issue.6, pp.22696-699, 1995. ,
DOI : 10.1016/0168-8278(95)80226-6
Prognostic value of Ishak fibrosis stage: Findings from the hepatitis C antiviral long-term treatment against cirrhosis trial, Hepatology, vol.44, issue.4 Suppl 1, pp.51585-594, 2010. ,
DOI : 10.1002/hep.23315
Diagnostic accuracy, reproducibility and robustness of fibrosis blood tests in chronic hepatitis C: A meta-analysis with individual data, Clinical Biochemistry, vol.41, issue.16-17, pp.4116-171368, 2008. ,
DOI : 10.1016/j.clinbiochem.2008.06.020
URL : https://hal.archives-ouvertes.fr/inserm-00324933
Overview of the diagnostic value of biochemical markers of liver fibrosis (FibroTest, HCV FibroSure) and necrosis (ActiTest) in patients with chronic hepatitis C, Comparative Hepatology, vol.3, issue.1, p.8, 2004. ,
DOI : 10.1186/1476-5926-3-8
A Meta-analysis of Transient Elastography for the Detection of Hepatic Fibrosis, Journal of Clinical Gastroenterology, vol.44, issue.3, pp.44214-219, 2010. ,
DOI : 10.1097/MCG.0b013e3181b4af1f
Optimization and robustness of blood tests for liver fibrosis and cirrhosis, Clinical Biochemistry, vol.43, issue.16-17, pp.16-171315, 2010. ,
DOI : 10.1016/j.clinbiochem.2010.08.010
URL : https://hal.archives-ouvertes.fr/hal-00868422
Sources of variability in histological scoring of chronic viral hepatitis, Hepatology, vol.20, issue.4Pt2, pp.257-264, 2005. ,
DOI : 10.1002/hep.20535
Comparison of test performance profile for blood tests of liver fibrosis in chronic hepatitis C, Journal of Hepatology, vol.46, issue.3, pp.395-402, 2007. ,
DOI : 10.1016/j.jhep.2006.09.020
Evaluating the accuracy and increasing the reliable diagnosis rate of blood tests for liver fibrosis in chronic hepatitis C, Liver International, vol.44, issue.10, pp.281352-1362, 2008. ,
DOI : 10.1111/j.1478-3231.2008.01789.x
URL : https://hal.archives-ouvertes.fr/inserm-00324938
Comparison of nine blood tests and transient elastography for liver fibrosis in chronic hepatitis C: The ANRS HCEP-23 study, Journal of Hepatology, vol.56, issue.1, 2011. ,
DOI : 10.1016/j.jhep.2011.05.024
URL : https://hal.archives-ouvertes.fr/hal-00866960
A New Combination of Blood Test and Fibroscan for Accurate Non-Invasive Diagnosis of Liver Fibrosis Stages in Chronic Hepatitis C, The American Journal of Gastroenterology, vol.42, issue.7, pp.1255-1263, 2011. ,
DOI : 10.1038/ajg.2011.100
A novel panel of blood markers to assess the degree of liver fibrosis, Hepatology, vol.39, issue.6, pp.421373-1381, 2005. ,
DOI : 10.1002/hep.20935
The combination of a blood test and Fibroscan improves the non-invasive diagnosis of liver fibrosis, Liver International, vol.29, issue.10, pp.291507-1515, 2009. ,
DOI : 10.1111/j.1478-3231.2009.02101.x
The STARD Statement for Reporting Studies of Diagnostic Accuracy: Explanation and Elaboration, Clinical Chemistry, vol.49, issue.1, pp.7-18, 2003. ,
DOI : 10.1373/49.1.7
Prediction of clinical outcomes in primary biliary cirrhosis by serum enhanced liver fibrosis assay, Hepatology, vol.49, issue.5, pp.481549-1557, 2008. ,
DOI : 10.1002/hep.22517
Diagnostic and prognostic values of noninvasive biomarkers of fibrosis in patients with alcoholic liver disease, Hepatology, vol.4, issue.1, pp.97-105, 2009. ,
DOI : 10.1002/hep.22576
Liver biopsy: The best, not the gold standard, Journal of Hepatology, vol.50, issue.1, pp.1-3, 2009. ,
DOI : 10.1016/j.jhep.2008.10.014
Impact of quality control accepted inter-laboratory variations on calculated Fibrotest/Actitest scores for the non-invasive biochemical assessment of liver fibrosis, Clinica Chimica Acta, vol.409, issue.1-2, pp.90-95, 2009. ,
DOI : 10.1016/j.cca.2009.09.005
Exceeding the limits of liver histology markers, Journal of Hepatology, vol.50, issue.1, pp.36-41, 2009. ,
DOI : 10.1016/j.jhep.2008.07.039
Prospective Analysis of Discordant Results between Biochemical Markers and Biopsy in Patients with Chronic Hepatitis C, Clinical Chemistry, vol.50, issue.8, pp.501344-1355, 2004. ,
DOI : 10.1373/clinchem.2004.032227
Independent Prospective Multicenter Validation of Biochemical Markers (Fibrotest-Actitest) for the Prediction of Liver Fibrosis and Activity in Patients with Chronic Hepatitis C: The Fibropaca Study, The American Journal of Gastroenterology, vol.38, issue.1, pp.547-555, 2006. ,
DOI : 10.1038/nm1006
Estimation of stage-specific fibrosis progression rates in chronic hepatitis C virus infection: A meta-analysis and meta-regression, Hepatology, vol.4, issue.2, pp.418-431, 2008. ,
DOI : 10.1002/hep.22375
Acoustic radiation force impulse: a new ultrasonographic technology for the widespread noninvasive diagnosis of liver fibrosis, European Journal of Gastroenterology & Hepatology, vol.22, issue.9, pp.1074-1084, 2010. ,
DOI : 10.1097/MEG.0b013e328339e0a1